ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in Chicago, IL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Cancer
Adenocarcinoma
Stomach Cancer
Ovarian Cancer
Neoplasm Metastasis

Pancreatic Cancer trials near Chicago, IL, USA:

Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source

control and the preferred method of attachment of the CivaSheet in the setting of suspected close or positive margins at the time of surgical tumor...

Enrolling
Pancreatic Cancer
Device: Directional Brachytherapy Source Implant

Phase 1, Phase 2

CivaTech Oncology

Chicago, Illinois, United States and 5 other locations

Subjects will be offered the opportunity to participate in a randomized, controlled, 2-arm, unblinded multicenter trial (RCT). There will be 2 study...

Active, not recruiting
Stage III Pancreatic Cancer
Drug: Modified FOLFIRINOX Regimen
Device: NanoKnife System

Phase 3

AngioDynamics
AngioDynamics

Arlington Heights, Illinois, United States and 5 other locations

Zolbetuximab is being studied as a treatment for people with pancreatic cancer. Most people with pancreatic cancer...

Active, not recruiting
Metastatic Pancreatic Adenocarcinoma
Metastatic Pancreatic Cancer
Drug: nab-paclitaxel
Drug: gemcitabine

Phase 2

Astellas
Astellas

Chicago, Illinois, United States and 135 other locations

in combination with gemcitabine and nab-paclitaxel in patients with Pancreatic Ductal Adenocarcinoma (PDAC) who have been previously untreat...

Active, not recruiting
Metastatic Cancer
Neoplasms Pancreatic
Drug: avutometinib (VS-6766) and defactinib in combination with gemcitabine and nab-paclitaxel

Phase 1, Phase 2

Verastem

Chicago, Illinois, United States and 11 other locations

This phase II study evaluates how well pemigatinib works for the treatment of adult patients with pancreatic cancer that has spread...

Enrolling
Metastatic Pancreatic Carcinoma
Stage IV Pancreatic Cancer AJCC v8
Drug: Pemigatinib
Procedure: Bone Scan

Phase 2

Sameek Roychowdhury

Chicago, Illinois, United States and 108 other locations

phosphorylase (MTAP)-deleted gastrointestinal, biliary tract, or pancreatic cancers. The study also aims to determine the safety...

Enrolling
Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers
Drug: Gemcitabine
Drug: Nab-paclitaxel

Phase 1

Amgen
Amgen

Chicago, Illinois, United States and 76 other locations

compared to just chemotherapy alone in participants with metastatic pancreatic cancer. One group of participants will only receive ...

Active, not recruiting
Metastatic Pancreatic Ductal Adenocarcinoma
Drug: Gemcitabine
Drug: Nab-paclitaxel

Phase 2

Agenus
Agenus

Arlington Heights, Illinois, United States and 35 other locations

Locations recently updated

The purpose of this study is to evaluate the safety and efficacy of atebimetinib in combination with modified GnP compared with SOC GnP alone.

Enrolling
Pancreatic Cancer Metastatic
Pancreatic Adenocarcinoma Metastatic
Drug: mGnP
Drug: GnP

Phase 3

Immuneering Corporation

Chicago, Illinois, United States and 5 other locations

TNG462-C102 is a Phase 1/2, open-label, multicenter study designed to determine the safety, tolerability, PK, PD, and preliminary antineoplastic acti...

Enrolling
Pancreatic Cancer Metastatic
PDAC - Pancreatic Ductal Adenocarcinoma
Drug: TNG462
Drug: gemcitabine/nab-paclitaxel

Phase 1, Phase 2

Tango Therapeutics
Tango Therapeutics

Chicago, Illinois, United States and 17 other locations

cancer, gastroesophageal junction cancer (GEJ cancer) or pancreatic cancer. GEJ is where the tube that ...

Enrolling
Pancreatic Adenocarcinoma
Gastroesophageal Junction (GEJ) Adenocarcinoma
Drug: Irinotecan
Drug: Leucovorin

Phase 1

Astellas
Astellas

Chicago, Illinois, United States and 45 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems